FIELD: medicine.
SUBSTANCE: what is presented is a method for reducing the concentration of cholesterol in blood plasma; for this purpose, the patient takes orally 1.0 g of allantoin 3 times a day, the course length is 90 days.
EFFECT: reducing the level of cholesterol and low-density lipoproteins in blood plasma.
1 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCING CONCENTRATION OF CHOLESTEROL IN BLOOD PLASMA | 2024 |
|
RU2834548C1 |
METHOD OF TREATING DIABETES MELLITUS | 2024 |
|
RU2834550C1 |
METHOD OF TREATING ALZHEIMER'S DISEASE | 2024 |
|
RU2834547C1 |
METHOD OF TREATING DIABETES MELLITUS IN COMPLEX WITH DALARGIN | 2023 |
|
RU2816021C1 |
METHOD OF TREATING KNEE OSTEOARTHRITIS | 2024 |
|
RU2822321C1 |
METHOD OF TREATING WRINKLES | 2024 |
|
RU2836513C1 |
KNEE OSTEOARTHRITIS TREATMENT GEL | 2024 |
|
RU2833711C1 |
AGENT FOR TREATING TROPHIC ULCERS ACCOMPANYING DIABETIC FOOT SYNDROME | 2024 |
|
RU2831547C1 |
METHOD OF TREATING CHRONIC KIDNEY DISEASE WITH DALARGIN | 2023 |
|
RU2819638C1 |
METHOD OF TREATING HYPOTHYROIDISM WITH DALARGIN | 2023 |
|
RU2814749C1 |
Authors
Dates
2025-03-18—Published
2024-11-30—Filed